Correlation between arachidonic acid oxygenation and luminol-induced chemiluminescence in neutrophils: Inhibition by diethyldithiocarbamate

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 927-935

  Chabannes, Bernard ^a,d   Perraut, Catherine ^a   El Habib, Raphaelle ^b   Moliere, Patrick ^a   Pacheco, Yves ^c   Lagarde, Michel ^a  

^a UNIVERSITÉ DE LYON   (France)

^b Pasteur Merieux Serums et Vaccins   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d INSERM   (France)

Author keywords

allergic patients; arachidonic acid and oxidative metabolism inhibition; chemiluminescence; diethyldithiocarbamate; neutrophils

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; DIETHYLDITHIOCARBAMIC ACID; LEUKOTRIENE B4; LUMINOL;

ADULT; ALLERGY; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; MALE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL;

ADULT; ARACHIDONIC ACID; CHEMILUMINESCENT MEASUREMENTS; DITIOCARB; FEMALE; HUMANS; HYPERSENSITIVITY; LEUKOTRIENE B4; LUMINOL; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATION-REDUCTION;

EID: 0030919247     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00832-5     Document Type: Article

References (47)

1. 4 in inflammation. Crit Rev Immunol 10: 1-12, 1990.
2. Köning W, Schönfeld W, Raulf M, Köller M, Knöller J, Scheffer J and Brom J, The neutrophils and leukotrienes - role in health and diseases. Eicosanoids 3: 1-22, 1990.
3. Lewis RA, Austen KF and Soberman RJ, Leukotrienes and other products of 5-lipoxygenase pathway. N Engl J Med 323: 645-651, 1990.
4. Rola-Pleszczynski M, T-cell activation. In: Advances in Inflammation Research (Eds. Lewis A, et al.), pp. 91-99. Raven Press, New York, 1988.
5. 4 in the immune system. Int J Immunopharmacol 14: 441-449, 1992.
6. Borgeat P and Samuelsson B, Metabolism of arachidonic acid in polymorphonuclear leukocytes: Effects of the ionophore A23187. Proc Natl Acad Sci USA 76: 2148-2152, 1979.
7. Rouzer CA and Kargman S, Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 263: 10980-10988, 1988.
8. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW and Miller DK, Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343: 282-284, 1990.
9. Rouzer CA and Samuelsson B, The importance of hydroperoxide activation for the detection and assay of mammalian 5-lipoxygenase. FEBS Lett 204: 293-296, 1986.
10. Riendeau D, Benis D, Choo LY and Nathaniel DJ, Stimulation of 5-lipoxygenase activity under conditions which promote lipid peroxidation. Biochem J 263: 565-572, 1989.
11. Riendeau D, Falgueyret JP, Nathaniel DN and Rokach J, Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides. Biochem Pharmacol 38: 2313-2321, 1989.
12. Hatzelmann A and Ullrich V, Regulation of 5-lipoxygenase activity by the glutathione status in human polymorphonuclear leukocytes. Eur J Biochem 169: 175-184, 1987.
13. Hatzelmann A, Schatz M and Ullrich V, Involvement of glutathione peroxidase activity in the stimulation of 5-lipoxygenase activity by glutathione-depleting agents in human polymorphonuclear leukocytes. Eur J Biochem 180: 527-533, 1989.
14. Müller-Peddinghaus R, In vitro determination of phagocyte activity by luminol- and lucigenin-amplified chemiluminescence. Int J Immunopharmacol 6: 455-466, 1984.
15. Mansour H, Levacher M, Gougerot-Pocidalo MA, Rouveix B and Pocidalo JJ, Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicity. J Pharmacol Exp Ther 236: 476-480, 1986.
16. Bruley-Rosset M, Vergnon I and Renoux G, Influences of sodium diethyldithiocarbamate, DTC (Imuthiol®) on T cell defective responses of aged BALB/c mice. Int J Immunopharmacol 8: 287-297, 1986.
17. 2-induced depression of T and B lymphocyte activation is reversed by diethyldithiocarbamate (DDC) treatment. Immunol Lett 18: 99-108, 1988.
18. Halpern MD, Hersh E and Yocum DE, Diethyldithiocarbamate, a novel immunopharmacomodulator, prolongs survival in autoimmune MRL-lpr/lpr mice. Clin Immunol Immunopathol 55: 242-254, 1990.
19. Hosni M, Meskini N, Prigent AF, Anker G, Joulain C, El Habib R and Lagarde M, Diethyldithiocarbamate (Ditiocarb sodium) effect on arachidonic acid metabolism in human mononuclear cells. Glutathione peroxidase-like activity. Biochem Pharmacol 43: 1319-1329, 1992.
20. Lang JM, Touraine JL, Trepo C, Choutet P, Kirstetter M, Falkenrodt A, Herviou L, Livrozet JM, Retornaz G, Touraine F, Renoux G, Renoux M, Musset M and Caraux J and the AIDS-Imuthiol French Study Group, Randomized, double-bind placebo-controlled trial of dithiocarb sodium "Imuthiol" in human immunodeficiency virus infection. Lancet ii: 702-706, 1988.
21. Reisinger EC, Kern P, Ernst M, Bock P, Flad HD, Dietrich M and German DTC study group, Inhibition of HIV progression by dithiocarb. Lancet 335: 679-682, 1990.
22. Hersh EM, Brewton G, Abrams D, Barlett J, Galpin J, Parkash G et al., Dithiocarb sodium (Diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA 265: 1538-1544, 1991.
23. Hosni R, Chabannes B, Molière P, Pachéco Y, Grosclaude M, Perrin-Fayolle M and Lagarde M, Leukotriene B4 levels from stimulated neutrophils from healthy and allergic subjects: Effect of platelets and exogenous arachidonic acid. Eur J Clin Invest 21: 631-637, 1991.
24. Paglia DE and Valentine WN, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169, 1967.
25. 4 level in neutrophils from allergic and healthy subjects stimulated by low concentration of calcium ionophore A23187. Effect of exogenous arachidonic acid and possible endogenous source. Biochim Biophys Acta 1093: 47-54, 1991.
26. 2. J Biol Chem 260: 6899-6906, 1985.
27. Mita H, Yui Y, Taniguchi N, Yasueda H and Shida T, Increased activity of 5-lipoxygenase in polymorphonuclear leukocytes from asthmatic patients. Life Sci 37: 907-914, 1985.
28. 2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 142: 157-161, 1990.
29. 4 synthesis. J Immunol 140: 4315-4322, 1985.
30. Dahinden CA, Zingg J, Maly FE and De Week AL, Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. J Exp Med 167: 1281-1295, 1988.
31. Styrt B, Rocklin RE and Klempner MS, Characterization of the neutrophil respiratory burst in atopy. J Allergy Clin Immunol 81: 20-26, 1988.
32. Alanko J, Riutta A, Mucha I, Vapaatalo H and Metsä-Ketelä T, Modulation of arachidonic acid metabolism by phenols: Relation to positions of hydroxyl groups and peroxyl radical scavenging properties. Free Radic Biol Med 14: 19-25, 1993.
33. Izumi Y, Ogino K, Murata T, Kobayashi H and Obara T, Effects of diethyldithiocarbamate on activating mecanisms of neutrophils. Pharmacol Toxicol 74: 280-286, 1994.
34. Burk RF, Glutathione-dependent protection by rat liver microsomal protein against lipid peroxidation. Biochim Biophys Acta 757: 21-28, 1983.
35. Bartoli GM, Müller A, Cadenas H and Sies H, Antioxidant effect of diethyldithiocarbamate on microsomal lipid peroxidation assessed by low-level chemiluminescence and alkane production. FEBS Lett 164: 371-374, 1983.
36. 2 and glutathione peroxidase on the elimination of membrane lipid peroxides. Arch Biochem Biophys 223: 441-452, 1983.
37. 2: Protection of membranes from lipid peroxidation damage. Trends Biochem Sci 12: 31-34, 1987.
38. Chakraborti S, Gurtner GH and Michael JR, Oxidant-mediated activation of phospholipase in pulmonary endothelium. Am J Physiol 257: L430-L437, 1989.
39. 2. FEBS Lett 309: 190-192, 1992.
40. Kemal C, Louis-Flamberg P, Kuprinski-Olsen R and Shorter AL, Reductive inactivation of soybean lipoxygenase 1 by catechols: A possible mechanism for regulation of lipoxygenase activity. Biochemistry 26: 7064-7072, 1987.
41. Nelson MJ, Batt DG, Thompson JS and Wright SW, Reduction of the active-site iron by potent inhibitors of lipoxygenases. J Biol Chem 266: 8225-8229, 1991.
42. Ozaki Y, Ohashi T and Niwa Y, A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attibuted to inhibition of the lipoxygenase pathway. Biochem Pharmacol 35: 3481-3488, 1986.
43. Chan AC, Tran K, Pyke DD and Powell WS, Effects of dietary vitamin E on the biosynthesis of 5-lipoxygenase products by rat polymorphonuclear leukocytes (PMNL). Biochim Biophys Acta 1005: 265-269, 1989.
44. Reddanna P, Whelan J, Burgess JR, Eskew ML, Hildebrandt G, Zarkower A, Scholz RW and Reddy C, The role of vitamin E and selenium on arachidonic acid oxidation by way of the 5-lipoxygenase pathway. Ann NY Acad Sci 570: 136-145, 1989.
45. Sakamoto W, Fujie K, Nishihira J and Handa H, Effect of vitamin E on arachidonic acid-release in rat peritoneal macrophages. Biochim Biophys Acta 1170: 296-300, 1993.
46. Niki E, Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 44: 227-253, 1987.
47. Robison TW, Sevanian A and Forman HJ, Inhibition of arachidonic acid release by nordihydroguaiaretic acid and its antioxidant action in rat alveolar macrophages and chinese hamster lung fibroblats. Toxicol Appl Pharmacol 105: 113-122, 1990.